The Combination of IDO and AHR Blockers Reduces the Migration and Clonogenicity of Breast Cancer Cells

Investigators evaluated the role of the indoleamine-2,3-dioxygenase (IDO) and aryl hydrocarbon receptor (AHR) blockers on cell migration, clonogenic, and IDO expression of murine breast cancer cells. The cell migration and clonogenic abilities of breast cancer cells were evaluated by wound‑healing assay and Colony formation assay.